BELAMAF Trademark

Trademark Overview

On Monday, May 4, 2020, a trademark application was filed for BELAMAF with the United States Patent and Trademark Office. The USPTO has given the BELAMAF trademark a serial number of 88899914. The federal status of this trademark filing is REGISTERED as of Tuesday, November 23, 2021. This trademark is owned by Glaxo Group Limited. The BELAMAF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders
belamaf

General Information

Serial Number88899914
Word MarkBELAMAF
Filing DateMonday, May 4, 2020
Status700 - REGISTERED
Status DateTuesday, November 23, 2021
Registration Number6565117
Registration DateTuesday, November 23, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of oncological diseases and disorders
Pseudo MarkBELANTAMAB MAFODOTIN

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, June 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 5, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, August 5, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 5, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, August 5, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, July 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 29, 2021ASSIGNED TO LIE
Tuesday, July 27, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, February 1, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, February 1, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, February 1, 2021SUSPENSION INQUIRY WRITTEN
Thursday, July 30, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 30, 2020LETTER OF SUSPENSION E-MAILED
Thursday, July 30, 2020SUSPENSION LETTER WRITTEN
Wednesday, July 29, 2020ASSIGNED TO EXAMINER
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 7, 2020NEW APPLICATION ENTERED

Related Keywords

belamaf diseases disorders oncological treatment preparations substances pharmaceutical